Effects of repeated ayahuasca administration on behaviour and c-Fos expression in rats exposed to the open field by Daldegan-Bueno, Dimitri Henriques
Dimitri Henriques Daldegan Bueno 
 
 
 
 
EFFECTS OF REPEATED AYAHUASCA ADMINISTRATION ON 
BEHAVIOUR AND C-FOS EXPRESSION IN RATS EXPOSED TO THE 
OPEN FIELD 
 
 
 
Dissertation presented to the Universidade 
Federal de São Paulo – Escola Paulista de 
Medicina, to obtain the title of Master in 
Science. 
 
 
 
 
 
 
 
 
São Paulo 
2020 
 
 
 
 
Dimitri Henriques Daldegan Bueno 
 
 
 
 
EFFECTS OF REPEATED AYAHUASCA ADMINISTRATION ON 
BEHAVIOUR AND C-FOS EXPRESSION IN RATS EXPOSED TO THE 
OPEN FIELD 
 
 
 
Dissertation presented to the Universidade 
Federal de São Paulo – Escola Paulista de 
Medicina, to obtain the title of Master in 
Science. 
 
 
Advisor: 
Dr. Maria Gabriela Menezes de Oliveira 
 
 
São Paulo 
2020 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Daldegan-Bueno, Dimitri 
Effects of repeated ayahuasca administration on behaviour and c-Fos 
expression in rats exposed to the open field / Dimitri Daldegan-Bueno. – São 
Paulo, 2020.  
xiv, 62f. 
Dissertação (Mestrado)–Universidade Federal de São Paulo. Escola 
Paulista de Medicina. Programa de Pós-Graduação em Psicobiologia. 
Título em português: Efeitos da administração repetida de ayahuasca no 
comportamento e na expressão de c-Fos em ratos expostos ao campo aberto. 
1.Ayahuasca. 2. c-Fos. 3.Open field 4. Amygdala. 5. Anxiety 6. Ethogram.  
 
 
 
 
UNIVERSIDADE FEDERAL DE SÃO PAULO 
ESCOLA PAULISTA DE MEDICINA 
GRADUATION PROGRAM OF PSYCHOBIOLOGY 
 
 
 
 
Department Head 
José Carlos Fernandes Galduroz 
 
Graduate Program Coordinator 
Vânia D'Almeida 
 
 
 
 
 
 
 
 
 
 
 
 
 
v 
 
v 
 
Dimitri Henriques Daldegan Bueno 
 
EFFECTS OF REPEATED AYAHUASCA ADMINISTRATION ON 
BEHAVIOUR AND C-FOS EXPRESSION IN RATS EXPOSED TO THE 
OPEN FIELD 
 
 
 
 
Board President: 
Dr. Maria Gabriela Menezes de Oliveira 
 
Examining Board: 
Dr. Luís Fernando Farah de Tófoli 
Dr. Sidarta Ribeiro 
Dr. Carlos Eduardo Neves Girardi 
 
 
 
 
 
 
 
 
 
 
  
vi 
 
vi 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
I dedicate this Master to my dear mother, 
whose restlessness work made possible 
for me to achieve a dream she never 
could. 
vii 
 
vii 
 
Acknowledgments 
 
I first express my gratitude to the entire life-support of my mother Marialva 
Daldegan, my best role model; for all the coding guidance/teachings of my brother 
Andrei Daldegan, and the support and influence of my sister Natássia Daldegan during 
my under-graduation formation. 
Then to my I advisor, Gabi (Gabriela de Oliveira) I have many gratitudes: for 
accepting me as her student with an ayahuasca project; for the orientation, trust and 
work-freedom; for all of our conversation, easy-going work environment and the many 
(so many!) laughs we shared. Finally, and perhaps the most important, I thank her for 
the authenticity role model.  
To all integrants of Gabi’s graduation group: for the support, orientation, 
corrections and comments from the very beginning and end of Vanessa 
Favaro Senpai; all the informal support, orientation and discussions of Thays dos 
Santos and Juliana Carlota; the experimental aid of Fabio Leonessa; and Márcio 
Braga, for all the conversations and bravery to eat UNIFESP lunch. 
To Paulo Morais for early science advise during my under-graduation and help 
to analyse the almost-unending behaviour videos of this project; Edilsom Fernandes, 
for carefully preparing and donating the ayahuasca used in this study; Fernando 
Cassas for all the assistance, but mainly, the companionship throughout the 
lyophilisation process. 
To the Psychedelic senior team Draúlio Araújo, Fernando Tófoli, Sidarda 
Ribeiro and Stevens Rehen for the role model of scientist and person; Alexandre 
Pontual and Lucas Maia for the friendship and all journeys we shared and continue to 
share; to the companionship and partnership of the dear Natália Simionato. 
To all the friends in Psychobiology Department that made this process lighter 
and pleasanter: Fábio Leonessa, Flávia Boos, Gabriela Campagnolli, Itamar Felix, 
Letícia Pichinin, Márcio Braga, Michelle Melo, Natália Simionato, Natália Zanta, Paula 
Sumaran, Ricardo França and Susy Tassini.  
To all 66 rats that had their lives sacrificed for this project. 
Finally, for the bravery and efforts of Alexandra Elbakyan for making science 
open to the world.  
 
viii 
 
viii 
 
  
ix 
 
ix 
 
Summary 
 
Acknowledgments .................................................................................................. vii 
Figure List .............................................................................................................. xi 
Abstract .................................................................................................................. xii 
Resumo ................................................................................................................. xiv 
1 INTRODUCTION .................................................................................................. 1 
2 OBJECTIVES ....................................................................................................... 6 
2.1 General ............................................................................................................. 6 
2.2 Specific ............................................................................................................. 6 
3 METHOD .............................................................................................................. 7 
3.1 Subjects ............................................................................................................ 7 
3.2 Ayahuasca ........................................................................................................ 7 
3.3 Doses and Groups ............................................................................................ 8 
3.4 Apparatus .......................................................................................................... 9 
3.5 Experimental Procedures .................................................................................. 9 
3.6 Perfusion and Microtomy ................................................................................ 10 
3.7 Immunohistochemistry .................................................................................... 11 
3.8 c-Fos Expression/Photography ....................................................................... 11 
3.9 Behaviours Computation ................................................................................. 12 
3.10 Behavioural Measures .................................................................................. 13 
x 
 
x 
 
3.11 Data Analysis ................................................................................................ 14 
4 RESULTS ........................................................................................................... 16 
4.1 Weight ............................................................................................................. 16 
4.2 Day one and Day 15 ....................................................................................... 17 
4.3 Open Field ...................................................................................................... 19 
4.4 c-Fos Expression ............................................................................................ 24 
5 DISCUSSION ..................................................................................................... 28 
5.1 c-Fos Expression ............................................................................................ 28 
5.2 Behaviour ........................................................................................................ 31 
5.2.1 Open Field.................................................................................................... 31 
5.2.2 Day one and 15 ............................................................................................ 34 
6 CONCLUSION .................................................................................................... 37 
7 REFERENCES ................................................................................................... 38 
Appendix 1 - Ethic Committee/Addendum Approval ............................................. 46 
 
 
  
xi 
 
xi 
 
Figure List 
 
Figure 1. Experimental design. .................................................................................. 10 
Figure 2. Weight gain after repeated ayahuasca administration................................ 16 
Figure 3. Effect of acute and repeated administration of ayahuasca. ........................ 18 
Figure 4. Effects of repeated ayahuasca administration in the open field. ................ 21 
Figure 5. Ambulation in the open field. ...................................................................... 22 
Figure 6. Path diagrams of behaviours transitions probability in the open field. ........ 23 
Figure 7. Immunoreactive nuclei reactive for c-Fos. C- ............................................. 25 
Figure 8. Effect of repeated ayahuasca administration in c-Fos expression. ............ 26 
Figure 9. Correlation between c-Fos expression and behaviours. ............................. 27 
 
  
xii 
 
xii 
 
Abstract 
 
Objective: To evaluate the behavioural and neurobiological effects of repeated 
ayahuasca administration in an animal model of exploratory behaviour related to novel-
environment anxiety. Method: Male Wistar rats received 120, 240, 480, 3,600mg/kg 
of resuspended lyophilised ayahuasca or water by gavage once a day for 30 days; 
there was also a non-manipulated homecage group. On the 1st and 15th day, animals 
were placed individually for five minutes into an acrylic cage for behavioural 
assessment; on the 30th day, animals were placed individually in the open field for 20 
minutes, followed by brain perfusion and removal (140min after last ayahuasca 
administration) for c-Fos immunoreactive analysis. All tests were done 60 minutes after 
the administration of ayahuasca. A stochastic analysis based on the ethogram of the 
animals were conducted to analyse the sequential structure of behaviours; weight was 
recorded during the entire process. Results: Acute low dose (120mg/kg) did not affect 
the behaviour but when administered repeatedly increased the ambulation and vertical 
exploration in the open field, while intermediate doses (240 and 480mg/kg) did not 
affect the behaviour either acutely nor repeatedly. Extreme high dose (3,600mg/kg) 
decreased vertical exploration both acutely and repeatedly, and animals in this group 
had a lower weight gain when compared to all groups, possibly due to the adverse 
effects that ayahuasca may induce; ethological analysis based on the ethogram 
confirmed these behavioural results. Aya3,600 had more c-Fos expression than water 
and aya120 in the medial CA1 region of the hippocampus; more expression than 
homecage, water, and aya120 in the anterior CA3 region of the hippocampus, and 
more expression than homecage and water in the medial infra-limbic cortex region. On 
the aya120 group, there was a negative correlation between the medial CA1 of the 
hippocampus and ambulation, time spent in rearing and a positive correlation between 
the medial CA1 and freezing behaviour; for aya3,600 there was a negative correlation 
between the anterior CA3 and time spent in rearing. No behavioural or neurobiological 
effects related to anxiety assessed by the open field were 
found. Conclusion: Different doses of repeated administration of ayahuasca have 
different effects on the exploratory behaviour evaluated by the open field; however, it 
did not alter the sequential structure of exploratory behaviour, even with an extremely 
high dose. Higher activation of areas involved in the emotional process and 
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serotonergic pathway add relevant material to the neurobiological literature of 
ayahuasca - specifically regarding the repeated/chronic ingestion. Extreme high doses 
of ayahuasca, even when administrated for 30 consecutive days, does not cause 
severe impairment in rats, providing further data regarding the safety of ayahuasca 
intake. Finally, our data do not support an anxiolytic effect of repeated ayahuasca 
related to the exploration of new anxiogenic-environment.  
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Resumo 
 
Objetivo: Avaliar os efeitos comportamentais e neurobiológicos da administração 
repetida de ayahuasca através de um modelo animal de comportamento exploratório 
em um ambiente novo e ansiogênico. Método: Ratos Wistar machos receberam 120, 
240, 480, 3.600mg/kg de ayahuasca liofilizada ressuspendida em água ou água por 
gavagem uma vez ao dia por 30 dias; houve também um grupo homecage não 
manipulado. Os animais foram colocados individualmente por 5 minutos em uma caixa 
de acrílico para avaliação do comportamento no 1° e 15° dia, no 30° dia, os animais 
foram colocados individualmente no campo aberto por 20 minutos, seguidos de 
perfusão e remoção do encéfalo (140 minutos após a última administração de 
ayahausca) para análise de núcleos imunoreativos para c-Fos. Todos os testes foram 
realizados 60 minutos após a administração da ayahuasca. Foi realizada uma análise 
estocástica baseada no etograma dos animais para investigar a estrutura sequencial 
de comportamentos, o peso foi registrado durante todo o processo. Resultados: A 
dose baixa (120mg/kg) quando administrada de forma aguda não teve efeito no 
comportamento, mas de forma repetida aumentou a ambulação e a exploração vertical 
no campo aberto, enquanto as doses intermediarias (240 e 480mg/kg) não afetaram 
o comportamento de forma aguda nem repetida. A dose mais alta (3.600mg/kg) 
diminuiu a exploração vertical tanto de forma aguda quanto repetida, os animais desse 
grupo apresentaram menor ganho de peso quando comparados com todos os grupos, 
provavelmente devido aos possíveis efeitos adversos induzidos pela ayahausca. A 
análise etológica baseada no etograma confirmaram esses resultados 
comportamentais. Aya3.600 teve mais expressão de c-Fos do que água e aya120 na 
região CA1 medial do hipocampo; mais expressão que o homecage, água e aya120 
na região CA3 anterior do hipocampo, e mais expressão que o homecage e água na 
região medial do córtex infra-límbico. No grupo aya120, houve uma correlação 
negativa entre o CA1 medial do hipocampo e a ambulação, tempo levantado (rearing) 
e uma correlação positiva entre o CA1 medial com o comportamento de congelamento 
(freezing); no grupo aya3.600, houve uma correlação negativa entre o CA3 anterior e 
o tempo levantado. Não foram encontrados efeitos comportamentais ou 
neurobiológicos relacionados à ansiedade avaliados pelo campo aberto. Conclusão: 
Diferentes doses repetidas de ayahuasca demonstraram um perfil de efeito diferente 
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no comportamento exploratório avaliado em pelo campo aberto, mas não alterou a 
estrutura sequencial do comportamento exploratório, mesmo com uma dose 
extremamente alta. Uma maior ativação de áreas envolvidas no processo emocional 
e via serotoninérgica agregam a literatura neurobiológica dos efeitos da ayahuasca - 
especificamente em relação à ingestão repetida/crônica. Doses extremamente altas 
de ayahuasca, mesmo administradas por 30 dias consecutivos, não parecem causar 
comprometimento graves em ratos, fornecendo dados adicionais sobre a segurança 
da ingestão da ayahuasca. Nossos dados não dão suporte para um efeito ansiolítico 
da ayahuasca relacionado à exploração de um novo ambiente ansiogênico. 
 
 
1 INTRODUCTION 
 
Ayahuasca is a psychedelic concoction of different Amazon psychoactive 
plants, being the most common form the decoction of the Banisteriopsis caapi vine 
and the Psychotria viridis leaf.(1) The vine possesses several beta-carbolines alkaloids, 
with harmine, harmaline, and tetrahydroharmine being more studied scientifically.(2) 
The main compost present in the leaf is the N,N-dimethyltryptamine (DMT), a 
tryptamine with no psychoactive effect if orally ingested, given the deamination 
process by the monoamine oxidase A (MAO-A) presented in the liver and the gut.(3, 4) 
Ayahuasca is only psychoactive because of the synergy between DMT (it’s mainly 
psychoactive compound) and the beta-carbolines, that act as competitive inhibitors of 
the MAO-A enzyme.(5, 6) DMT acts mainly as serotoninergic receptor 5-HT1a, 5-HT2a 
e 5-HT2c agonist, which is particularly expressed in the neocortex, striatum, raphe 
nucleus dentate gyrus and CA1 field of the hippocampus and amygdaloid nucleus 
brain regions, but is also a sigma-1 receptor ligand.(7-9) 
Recent reviews indicate a therapeutic potential of ayahuasca for the treatment 
of anxiety and depression.(1, 10) Accordingly, long-term ayahuasca users have better 
scores in anxiety and depression measurements when compared to controls,(11) and 
first-time ayahuasca consumption may reduce anxiety and depression symptoms six 
months after.(12) However, there are several limitations and challenges when 
investigating the pharmacological ayahuasca effects in humans, such as the social 
and/or religious context where it is often consumed or the mystical-type experience 
peculiar to the psychedelics experiences.(13) In that sense, a single dose of ayahuasca 
given to naïve subjects decreased the symptoms of treatment-resistant depression in 
a randomized placebo-controlled trial, a design that controlled the social/religious 
context.(14)  
Neuroimage studies can also assess the effects of ayahuasca in a biological 
level within a controlled setting, and such studies indicate that acute ayahuasca 
ingestion leads to activation of brain structures involved in episodic and working 
memory, and the processing of contextual associations and emotion such as the 
amygdala, parahippocampal gyrus, and frontal and paralimbic areas (for review see 
Dos Santos et al., 2016)(10). For instance, a randomized, double-blind clinical trial with 
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Single Photon Emission Computed Tomography (SPECT) revealed higher activation 
of the frontal and paralimbic brain regions, and higher blood flow in the anterior insula, 
cingulate cortex, amygdala and parahippocampal gyrus.(15) Another SPECT study with 
a single dose of ayahuasca in depressive patients showed increased blood flow in the 
left nucleus accumbens, right insula, and subgenual area.(16) Using functional 
magnetic resonance imaging (fMRI), the acute ayahuasca effects in frequents users 
was found to be associated with higher activation in several occipital, temporal and 
frontal areas, including the middle occipital parahippocampal, posterior cingulate, 
superior temporal, superior middle, and inferior frontal gyri.(17) Another fMRI study 
associated ayahuasca ingestion with a decreased activation through most of the 
default mode network - a group of brain regions associated with internally oriented 
mental process - including the posterior cingulate cortex/precuneus and medial 
prefrontal cortex.(18) Regarding long-term ayahuasca users (and matching controls), 
an investigation with MRI found an association with ayahuasca use and cortical 
thinning in mensotemporal and inferior frontal gyri, precuneus, superior frontal gyrus, 
and an increased thickening in the precentral gyrus and cingulate cortex.(19) 
Altogether, these results suggest that ayahuasca affects key neural systems related 
to the regulation of mood and emotional processing, possibly involving the role of the 
serotonergic neurotransmission. Nevertheless, the appraisal elements such as 
subjective effects and mystical-type experience still occur and may account for the 
observed effects even in a clinical experimentation setting; thus, animal models allow 
the study of the pharmacological effects controlling these interferences. Even though 
the psychedelic effects per se cannot be assessed within an experimental animal 
model, it’s behavioural effects can be systematically investigated.  
Evidence from animals’ studies that received an acute ayahuasca dose showed 
that both ayahuasca and its alkaloids alone might have therapeutic properties. For 
instance, harmine showed a dose-dependent effect on anxiety evaluated in the 
elevated plus-maze test,(20) and antidepressant effect by reducing immobility time, 
increasing time of climbing and swimming in the forced swimming test.(21) Also, acute 
low doses of DMT produces an anxiogenic effect, while it`s long-lasting effects tend to 
reduce anxiety by facilitating the extinction of cued fear memory.(22) These findings 
suggest that both harmine and DMT may contribute to the possible antidepressant 
and anxiolytic effects of ayahuasca; however, the behavioural effects of the alkaloids 
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altogether, as it occurs in ayahuasca, may be different, since DMT may interfere in the 
behavioural profile of the beta-carbolines.(23) But similarly, the acute effect of low doses 
of ayahuasca in rats decreased immobility time in the forced swimming test and 
decreased the locomotor activity and vertical exploration in the open field,(24) while 
acute moderate doses decreased locomotion in the open field.(25) Acute administration 
did not modify spontaneous locomotor in a habituated open field but inhibited early 
behaviours associated with the initiation of ethanol addiction and effectiveness in 
reversing long-term ethanol-induced behavioural sensitization.(26) Altogether, showing 
that the acute administration of ayahuasca, and not only its alkaloids individually, have 
effects on the behaviour of rodents related to pre-clinical anxiety and depression 
model. Furthermore, acute administration of ayahuasca also led to a higher rate of 
inhibitory amino acids liberation in the hippocampus, and a higher rate of monoamines 
usage by the amygdala in rats.(27) 
In the matter of investigating the neurobiology of ayahuasca (or other drugs), 
one useful and widespread method to study the topography of activated brain 
structures is through the expression of c-Fos marked neurons.(28) c-Fos is an 
immediate-early-gene induced by extracellular stimuli that codify an essential protein 
for the subsequent events of the cell: the Fos protein. The c-Fos 
immunohistochemistry thus marks the nucleus of an activated cell and can be used as 
a marker of activated neurons.(29, 30) In that sense, a study investigating the c-Fos 
expression in rats after acute administration of ayahuasca followed by exposure to the 
open field found that treated animals have increased c-Fos expression in the dorsal 
raphe nuclei, amygdaloid nucleus, and hippocampal formation; another study found 
higher c-Fos expression in the nucleus accumbens of rats chronically treated with 
alcohol and then exposure to ayahuasca for five days when compared to non-
ayahuasca exposure controls.(25, 31) Moreover, it is also known that the activation of 5-
HT2a receptors stimulates the expression of immediate early genes, including c-Fos 
in the medial prefrontal and anterior cingulate cortices, it can modulate the plasticity 
of synapses by increasing brain-derived neurotrophic factor and inducing the 
expression of transcription factors egr-1 and egr-2 (32-36). 
Despite most of the available studies both in humans and non-human animals 
assess the acute effect of ayahuasca, studies with repeated administration is 
essential, given that many of the ritualistic ayahuasca use are done repeatedly, during 
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long periods of one’s life.(37) The difficulty of studying long-term ayahuasca is another 
advantage of using animal models; however, to our knowledge, there are only three 
studies that investigated the effects of repeated administration of ayahuasca in such 
models: two tested the behaviours one day after the last administration and one with 
the rats` offspring. Daily administration of ayahuasca in mothers rats during pregnancy 
and lactation reduced the anxiety of the offspring evaluated by the elevated plus-maze 
test, (38) but the administration twice a week for periods ranging from one week up to 
12 weeks did not change anxiety, learning and memory parameters evaluated by the 
open field, elevated plus-maze and Morris water maze.(39) In our laboratory, we 
showed that daily administration of ayahuasca for 30 consecutive days increased 
freezing time, the parameter used to evaluate the fear conditioning learning, but 
haven’t changed either anxiety or the learning measures evaluated by the elevated 
plus-maze and the Morris water maze, showing that repeated administration of 
ayahuasca may interfere in the contextual association of the emotional events in rats. 
(40). Altogether, these studies suggest a different profile from the acute and the 
repeated effect of ayahuasca, however, in all the repeated administration studies, 
animals were either the offspring of mother’s that received ayahuasca or were 
evaluated in an off-drug state.  
Considering (1) the worldwide expansion of ayahuasca and its ongoing growth 
of therapeutic evidence, (2) the association between its acute administration in rats 
with an increase of neuronal activation in key emotional processing areas involved in 
the behavioural response of anxiety, and that (3) repeated administration can interfere 
the context-association of emotional processing and learning; it is opportune to 
investigate the relationship of long-term ayahuasca treatment on brain activation of 
structures related to emotional processing. Therefore, the objective of this work was 
to evaluate the behavioural and neurobiological effects of repeated ayahuasca 
administration in an animal model of exploratory behaviour related to anxiety. 
According to Prut & Belzung (2003),(41) the open field is a model for anxiety that is 
triggered by the agoraphobia and individual testing, where rodents tend to walk close 
to the wall while exploring a new environment. Increased locomotion in the central part 
of the apparatus or time spent on it without total locomotion and vertical exploration 
modification can be interpreted as an anxiolytic behaviour, while the decrease of these 
parameters suggests an anxiogenic behaviour. A general increase in locomotion is 
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associated with a stimulant effect, while the decrease of vertical activity and 
locomotion are related to sedation. Since much of the information regarding 
behaviours and its variability resides in the sequential organization of it,(42) an 
ethological approach with ethogram was performed followed by stochastic analysis to 
investigate the transition among different behaviours. Due to the potential anxiolytic 
effect of ayahuasca in humans and some of its components in animals,(1, 10) we 
hypothesized that ayahuasca would cause anxiolytic-type behavioural responses in 
the open field (i.e., more activity in the inner quadrant) and less expression in the 
amygdaloid nuclei. Given that our design involved a chronic group with extreme high 
ayahuasca dose, we measured the weight throughout the process as a measure of 
health status and to verify the safety/toxicity of ayahuasca intake. (43, 44) 
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2 OBJECTIVES 
 
2.1 General  
 
To evaluate the behavioural and neurobiological effects of repeated ayahuasca 
administration in an animal model of exploratory behaviour related to novel-
environment anxiety. 
2.2 Specific 
 
Evaluate c-Fos expression by mm² in rats brain regions related to emotional 
processing after repeated ayahuasca administration followed the exposure to the open 
field. 
Evaluate the acute/repeated effects of ayahuasca administration on the 
behavioural response of rats in a novel environment. 
Evaluate the exploratory behaviour response with a transition probability of 
ethogram in rats after repeated ayahuasca administration followed the exposition to 
the open field.  
Evaluate the anxiety-related behavioural response of a novel environment in 
rats after repeated ayahuasca administration followed the exposition to the open field.  
Evaluate weight gain of rats that received daily doses of ayahuasca for thirty 
days.       
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3 METHOD 
 
3.1 Subjects 
 
Male Wistar rats, 12 weeks older (300-350g) were provided by the Centro de 
Desenvolvimento de Modelos Experimentais para Medicina e Biologia (CEDEME) of 
the Universidade Federal de São Paulo. Animals were housed in groups of 4 or 2 rats 
per cage in a 22+-1°C temperature room, with 12-hour light/dark cycle (lights on at 
7:00 a.m.). Food and water were available ad libitum and animals had seven days of 
habituation before the start of experiments. All procedures were approved by the 
Ethics Committee for Animal Research of Universidade Federal de São Paulo (CEUA 
n° 7674310817, Appendix 1), in accordance with the National Council for Animal 
Experimentation (CONCEA [“Conselho Nacional de Experimentação Animal”]) current 
norms and as well as international norms (45-47).  
 
3.2 Ayahuasca  
 
The ayahuasca brew was derived from the religious institution Barquinha 
located in Rondônia (Brazil) which uses it as a sacrament in their rituals. The institution 
head signed a consent form after being informed regarding the design of the study. 
The ayahuasca was freeze-dried through the following procedure: ayahuasca was first 
placed in the rotary evaporator at 70°C until it reaches half of the initial volume, then 
it was frozen and placed in the freeze drier with a pressure of -4ATM, -55°C for 
approximately 72 hours; the final product was stored in a desiccator inside a 
refrigerator at 6°C. A quantitative analysis of the ayahuasca alkaloids was performed 
with liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) by the 
Institute of Chemistry of University of Campinas (UNICAMP) both for the liquid and 
freeze-dried material.(48) Although there is yet no study in the literature comparing the 
effects of freeze-dried and liquid forms of ayahuasca, the freeze-dried form was 
already used in several studies that found relevant physiological, behavioural and 
subjective effects in both animals and humans;(25-27, 31, 40, 49, 50) also, we found very 
similar alkaloids quantity between the liquid and freeze-dried sample (Table 1). 
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Table 1. Ayahuasca alkaloids quantification by LC-MS/MS. 
  DMT 
(mg/L) 
THH 
(mg/L) 
HME 
(mg/L) 
HML 
(mg/L) 
     
Liquid sample 267 (3) 685 (13) 947 (10) 51.3 (0.3) 
     
Freeze-dried 
sample* 
250 (4) 629 (27) 996 (6) 52 (2) 
Mean value and standard deviation of three analysis (n=3). Abbreviations: N,N-dimethyltryptamine 
(DMT), tetrahydroharmine (THH), harmine (HME), and harmaline (HML) concentration by grams in a 
litre. *Freeze-dried sample was resuspended in water with the original proportion for quantification (1 
mL of ayahuasca rendered 150 g of dried extract). The mean equivalent concentration of alkaloids for 
the dried extract are: DMT: 37.5 mg/g; THH: 94.44mg/g; HME: 149.55mg/g, and HML: 7.80mg/g. 
 
3.3 Doses and Groups 
 
Freeze-dried ayahuasca extract was used for experimentation, with a standard 
dose of 240mg/kg based on the quantity of DMT of previous studies in both humans 
and animal that found significant effect (40, 51). The following ayahuasca experimental 
groups were utilized:  half (120mg/kg), standard dose (240mg/kg), double (480mg/kg), 
and 15 times fold (3,600mg/kg) the standard dose, totalizing six experimental doses 
(120, 240, 480 and 3,600 mg/kg, control, homegace). This quantity of doses was used 
to investigate if different doses have different effect profile and to achieve a larger 
dose spectrum, given that ayahuasca effects on the central nervous system depend 
on the deamination of the MAO enzymes in the digestive tract and it bioavailability 
may differ between species. The freeze-dried extract was diluted in water at the 
beginning of each week and administered orally by gavage; the control group received 
water with the same procedure. Gavage of all dosages was standardized with a 
volume of 1.5mL (approximately 5mL/kg) and was given every day between 10:00 
a.m. and 12:00 a.m., except for the experimental days (from 9:00 a.m. to 3:00 p.m.). 
There was also a homecage group with animals that were not manipulated unless for 
weighting and euthanasia procedures. Eleven animals were used per group (total 
sample = 66) but results from different measures have different samples due to 
experimental intercurrences.  
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3.4 Apparatus 
 
Acrylic Cage: A round, transparent acrylic cage with a diameter of 18cm and 
walls of 38cm. 
Open Field: The open field is a widely use apparatus in animal models; it was 
developed by Hall (1934)(52) for the study of emotionality in rats. Different versions are 
available nowadays, but its main concept consists of an open environment with 
surrounding walls that make it impossible for animals to escape from it. Our open field 
consisted of a round white wood apparatus with 96cm of diameter, 34cm walls and 
with the surface marked with 19 quadrants. 
 
3.5 Experimental Procedures 
 
Different groups of animals received daily oral dose of water or ayahuasca (120, 
240, 480 and 3,600 mg/kg) for 30 days. On the 1th and 15th day, 60 minutes after the 
administration, animals were placed individually into the acrylic cage for five minutes. 
On the 30th day, 60 minutes after the administration, animals were placed individually 
into the centre of the open field, always facing the same direction, for 20 minutes. 
Eighty minutes after the exposure to the open field (140min after the administration), 
animals were anaesthetized. Ten minutes after the anaesthesia, animals were 
perfused and had their brains removed for histological procedures (total time after 
ayahuasca administration: 150min). The time of 150 minutes for histological evaluation 
was utilized to assess the c-Fos expression when animals were in the open field while 
under the effect of ayahuasca (60 minutes for ayahuasca to have effect plus 90 
minutes for the c-Fos expression) based on previous studies.(25, 53, 54) All of the 
behavioural procedures were filmed for posterior (blinded) behavioural analysis and 
all animals were weighed on the day before the beginning of gavages and the 29° day 
(Figure 1). 
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Figure 1. Experimental design. 
 
3.6 Perfusion and Microtomy 
 
 For c-Fos expression analysis, 140 minutes after the last administration of 
ayahuasca, animals from all six groups were anaesthetized with an intraperitoneal 
injection of barbituric sodium thiopental (150mg/kg) together with lidocaine (10m/kg). 
Ten minutes later, animals were intracardially perfused using a peristaltic pulp; 
cannula was inserted in the left ventricle followed by the perforation of the right atrium. 
Perfusion was initiated with 10mL of saline (0.9%) during one minute, followed by 
150mL of a fixative solution of paraformaldehyde (4% in water, pH 9,5 at 4ºC) during 
15 minutes. Brains were post-fixed for one hour at 4°C in the same fixative solution, 
then placed in a 30% sucrose solution in KPBS pH 7,4 (phosphate-buffered saline 
solution containing potassium) until they had sunk, then frozen with dry ice and stored 
at a -80 ºC freezer. Each brain was sectioned in four series of frontal slices (30μm) in 
a Cryostat at -22°C and slices were stored in an anti-freezing solution (sucrose diluted 
in a KPBS solution, ethylene glycol, and water) in a -20 ºC freezer; one of the four 
series was cored with Cresyl violet and used as a cytoarchitectonic reference. The 
experimenter was blinded in all the steps. 
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3.7 Immunohistochemistry  
 
Brain slices were retrieved from the anti-freezing solution and washed three 
times for 10 min in KPBS 0.02M, then washed for 20min in a 0.3 % hydrogen peroxide 
in KPBS 0.02M solution and then washed three times for 10min in KPBS 0.02M again. 
Slices were then pre-incubated in a 3% goat serum in KPBS 0.02M solution for 60min 
and then incubated in a polyclonal antibody anti-C-Fos (concentration of 1:5,000) in 
KPBS 0,02M and 3% normal goat serum for 48 hours at 4°C. The detection of the 
primary antibody was made through indirect immunoperoxidase using the avidin-biotin 
complex (ABC kit). The immunohistochemistry reaction was revealed using a 3,3-
diaminobenzidine tetrahydrochloride (DAB 0.05%) with nickel and H2O2 for the limit of 
10 minutes. The reaction was stopped with three 10 minutes washes with KPBS 
0.02M, resulting in a dark-purple mark of c-Fos immunoreactive neurons. Finally, 
slices were mounted in gelatinized slides, air-dried, dehydrated in ethanol and xylol 
batteries and covered with coverslips using DPX Mountant (44581, Sigma). Negative 
control for non-specific background staining was done previously by our group (data 
not shown); in addition, the serum goat aids to reduce non-specific staining and other 
studies have previously published using immunohistochemistry with the same primary 
antibody. (55-57) The experimenter was blinded in all steps.  
 
3.8 c-Fos Expression/Photography 
 
For c-Fos immunoreactive nuclei analysis, one image for each hemisphere of 
three longitudinal (anterior, medial, and posterior) spacing of nine different regions 
was acquired. Only slices from the experimental groups that showed modified 
behavioural response by ayahuasca and the controls groups of were analysed: 
homecage, water, aya120, and aya3,600 (n=36); Table 3 shows all regions and the 
total number of photos taken/analysed. All images were photographed with an optic 
microscope (Olympus) equipped with different emission of wavelength using a 10x 
zoom lens, photos using 4x zoom lens were also taken to aid the identification of 
regions. For each image, we drew the boundaries of structures using Paxinos & 
Watson (2007)(58) as a topographic reference, convert it to 8-bit format, then manually 
adjusted the threshold in order to avoid misquantification due to immunohistochemistry 
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background differences, and quantified the quantity of marked c-Fos immunoreactive 
neurons using the image analysis software Image J (Version 1.52t). Final data were 
reported through the c-Fos expression within the regional area in millimetres 
(cell/mm²). The experimenter was blinded in all the described steps. The number of 
photos analysed by regions and subregions is described in Table 2. 
 
Table 2. Number of photos taken for each animal. 
Region Subregion Hemisphere Location Total 
Photos 
 
 
Amygdala 
Basolateral 2 3  
18 
 Lateral 2 3 
Central 2 3 
     
 
 
Hippocampus 
CA1 2 3  
18 
CA2 2 3 
Dentate gyrus 2 3 
     
Cortex Infra-Limbic 2 3 12 
Pre-Limbic 2 3 
     
Barrel Field 
Cortex 
S1BF 2 3 6 
     
Total Photos    54 
Photos were taken for nine regions: (1) basolateral, (2) lateral and (3) central nucleus of the amygdala, 
(4) CA1, (5) CA3 and (6) dentate gyrus of the ventral hippocampus, (7) infra-limbic and (8) pre-limbic 
cortex, and (9) barrel field cortex. One photo for each hemisphere (right and left), and one photo per 
each location (anterior, medial, and posterior). Totalizing 1,923 photos ([54 * 36 animals minus] - 21 
[data loss]).  
 
3.9 Behaviours Computation 
 
An ethogram based on several behaviours were computed with the recorded 
videos by a blinded experimenter. Given the small number of (some) behaviour’s 
occurrences, behaviours were merged accordingly with its classes (e.g., walk and turn 
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into horizontal exploration) or excluded from the ethogram analysis (e.g., wet dog 
shake, rear walk). Utilized behaviours on the ethogram are described in Table 3.  
Table 3. Ethogram of rat behaviour 
Immobile sniffing 
(IS) 
rat sniffs the environment while stands on the apparatus 
ground, without locomotion. 
  
Freezing 
(FR) 
total immobility except for vibrissae and breathing 
movements. 
  
Vertical 
exploration* (VE) 
(1) rearing with forepaws towards the wall: rat maintains an 
erect posture with leaning against the wall. (2) rearing with 
freehand: rat maintains an erect posture without leaning 
against the wall. 
  
Horizontal 
exploration*  
(HE) 
(1) walk: rat moves around sniffing, changing position; (2) 
turn: rat moves back paws and changes direction 
translationally.  
  
Grooming* 
(GROM) 
(1) face grooming: rat rubs any part of the face with rapid 
circular movements of the forepaws. (2) body grooming: rat 
licks its body. (3) paw licking: rats lick or groom its forepaws 
or back paws. 
Abbreviations in brackets. *Classes of behaviours that are composed by two or more behaviours; 
number between parentheses indicates individuals behaviour, adapted from Casarrubea, Sorbera, 
Santangelo, & Crescimanno (2011) . 
 
3.10 Behavioural Measures 
 
For day one, day 15 and day 30, the following measures were computed: 
1. Ethogram developed based on the transition of behaviours. 
2. Frequency of (1) all behaviours, (2) vertical exploration, (3) horizontal 
exploration, (4) immobile sniffing, (5) freezing, (6) grooming, (7) wet dog 
shake and (8) rear walk.  
3. Quantity of faecal balls and urination. 
4. Time spent in (1) rearing, (2) grooming and (3) freezing.  
For day 30, the additional measures we also computed. 
1. (1) Total ambulation (number of quadrants crossed in the arena), (2) 
ambulation in the inner quadrant, (3) inner quadrants entries, (4) time spent 
14 
 
 
in the inner quadrant, (5) latency to first get out of the inner quadrant, and 
(6) latency of behaviours first appearance.  
2. Frequency of behaviours in the inner quadrant. 
 
3.11 Data Analysis 
 
Data from day one and day 15 were paired and analysed with generalised 
estimating equations (GEE) with the distribution that showed the best fit (QIC 
criterion). For independent measures, data were analysed using the generalized linear 
model (GZLM) with the distribution that showed the best fit (AIC criterion). Planned 
post-hoc comparisons were performed comparing ayahuasca with water using the 
Least Significance Differences (LSD) when a significant effect was detected. Weight 
was analysed by its delta (day 29 – baseline) and standardized by the homecage 
group; the others group were tested based on the percentage difference with the 
GZLM. Some compounds in the open field, depending on dosage or procedure, may 
increase or decrease activity in it, potentially leading a modification in the number of 
entries in the central part of the apparatus.(41) To overcome this problem, we analysed 
our measures of the inner quadrant using the total ambulation as a covariate, and 
analysed the ratio between inner quadrant entries and ambulation.(60).We also 
evaluated the ambulation repeatedly in three blocks of five minutes with GEE in order 
to assess habituation. For the quantitative aspects of behaviours (frequency and per 
cent distribution), a descriptive approach was utilized.  
For each group, the mean number of behaviours and total time spent on it was 
evaluated as well as the mean number of behaviour transitions of the ethogram. A 
multivariate approach based on transition matrix was used. Transition matrices were 
constructed for each group by summing every sequence of behaviours of every animal 
in the group. Every transition matrix adopts the following criterion: [1] a minimum 
number of transitions at least five times the number of selected behavioural pattern. 
[2] No more than 20% of the cells may contain value lower than five.(42) The transition 
matrix was then transformed into a probability matrix in a way that [1] switching 
probability from a component to all other is 1; [2] all cells in the matrix range from 0 to 
1; [3] each row must sum one (100%).(59) Each probability matrix was graphically 
expressed through path diagram, with transitional probabilities represented by 
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different connecting arrows. Probability matrices were calculated by a code developed 
in R (V. 3.6.3). Transitions were compared between group based on the frequency of 
occurrence.  
For the c-Fos expression, laterality for each region was tested for the whole 
sample using GZLM with the distribution with the best fit. As none of the regions 
showed difference on the hemisphere c-Fos expression, data from the two 
hemispheres were combined by their means, resulting in 27 variables to analyse (nine 
regions times three spatial locations). c-Fos expression was finally tested using GZLM 
with the distribution with the best fit, followed by the LSD post hoc when necessary. 
We conducted a Spearman correlation for each group comparing regions with 
statistically a significant difference of c-Fos expression with the following behaviours 
of the open field: rearing, freezing and ambulation. All analysis was conducted using 
IBM SPSS statistics (v.23) and a p-value equal or less than 0.05 was considered 
statically significant. 
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4 RESULTS 
 
4.1 Weight 
 
GZLM for linear distribution (AIC = 258.372) with the percentage of weight gain 
standardized by homecage group showed a significant group effect (W(5) 16.241, p = 
0.003); aya3,600 showed a significant lower weight gain when compared to all groups 
(p < 0.05) (Figure 2). 
Figure 2. Weight gain after repeated ayahuasca administration. Percentage of weight gain from 
baseline to day 29 standardized by homecage group. *Indicates a significant difference of aya3,600 
groups compared to all groups (aya120 p = 0.02; aya240 p = 0.001; aya480 p = 0.002; water p = 0.038). 
Graphic bars represent mean values and error bars represents a 95% confidence interval bootstrapped 
1,000 times for water, homecage or ayahuasca doses of 120 (aya120), 240(aya240), 480(aya480) and 
3,600 (aya3,600) mg/kg. Black dots are the individual values of animals. The number of animals per 
group is shown in parentheses below group names.  
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4.2 Day one and Day 15 
 
GEE detected a time effect for the total time spent in rearing (Tweedie, QIC = 
433.581, W(4) = 12.738, p < 0.001) and grooming behaviours (Gamma, QIC = 50.227, 
W(4) = 43.371, p < 0.001); there was a decrease in time spent in these behaviours on 
day 15 when compared to day one. GEE detected a time effect for the total frequency 
of behaviours (Negative binomial, QIC = 16.003, W(4) = 81.071, p < 0.001), vertical 
exploration (Negative binomial, QIC = 88.593, W(4) = 39.093, p < 0.001), horizontal 
exploration (Negative binomial, QIC = 56.642, W(4) = 104.964, p < 0.001) and 
immobile sniffing (Negative binomial, QIC = 11.120, W(4) = 38.498, p < 0.001); all of 
the frequencies decreased on day 15 when compared to day one. 
GEE detected a time effect for the frequency of transitions from immobile 
sniffing to horizontal exploration (Negative binomial, QIC = 51.585, W(4) 47.086, p < 
0.001), from immobile sniffing to vertical exploration (Negative binomial, QIC = 66.142, 
W(4) = 28.820, p < 0.001), from horizontal exploration to immobile sniffing (Negative 
binomial, QIC = 50.112, W(4) = 57.378, p < 0.001), from horizontal exploration to 
vertical exploration (Negative binomial, QIC = 97.184, W(4) = 21.316, p < 0.001), from 
vertical exploration to immobile sniffing (Negative binomial, QIC = 67.798, W(4) = 
27.366, p < 0.001). All the frequencies decreased on day 15 when compared to day 
one. For the transition of freezing to immobile sniffing, GEE detected a close 
significance for time effect (Negative binomial, QIC = 32.545, W(4) 3.590, p = 0.058) 
with an increase of the frequency in day 15 when compared to day one.  
GEE for Negative for binomial distribution (QIC = 88.593) detect a time effect 
(W(4) = 39.093, p <0.001) and an interaction effect between group and time (W(4) = 
9.444, p = 0.051) for the frequency of vertical exploration. There was an overall 
decrease of vertical exploration in day 15 when compared to day one. The mean 
frequency of aya3,600 on day one (p = 0.011) was significantly lower when compared 
to the mean of water on day one. On day 15, the frequency of aya240 (p = 0.014), 
aya480 (p = 0.002) and aya3,600 (p < 0.001) were significantly lower when compared 
to the frequency of water group on day one (Figure 3).  
GEE detected a group effect for the frequency of transition immobile sniffing to 
vertical exploration (Negative binomial, QIC = 66.142, W(4) = 13.892, p = 0.008), post 
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hoc analysis showed that aya240 (p = 0.045), aya480 (p = 0.062) and aya3,600 (p < 
0.001) had less transitions than water. GEE detected a group effect for the frequency 
of transition from vertical exploration to immobile sniffing (Negative binomial, QIC 
=67.798, W(4) = 10.451, p = 0.033), post hoc analysis showed that aya3,600 (p = 
0.001) had fewer transitions than water. 
 
Figure 3. Effect of acute and repeated administration of ayahuasca. *Indicates a significant effect 
of time (p < 0.001). ** Indicates a significant difference when compared to the water group on day 1. 
Mean frequency of aya3,600 (p = 0.011) was significantly lower than the mean frequency of water group 
on day one. *** Indicates da significantly difference of water, aya240 and aya480 when compared to 
their selves on day one. Mean frequency water (p = 0.005), aya240 (p = 0.003) and aya480 (p < 0.001) 
were significantly lower. Graphic points represent mean values and error bars represents a 95% 
confidence interval bootstrapped 1,000 times for water or ayahuasca doses of 120 (aya120), 
240(aya240), 480(aya480) and 3,600 (aya3,600) mg/kg. The number of animals per group is shown in 
parentheses after group names.  
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4.3 Open Field 
 
GZLM for linear distribution (AIC = 484.603) showed a significant group effect 
for ambulation (W(4) = 15.076, p = 0.005), aya120 had higher ambulation than the 
water group(p = 0.055, Figure 4A). For time spent in the inner quadrant, GZLM for 
gamma distribution (AIC = 529.547) showed a significant group effect (W(4) = 16.782, 
p = 0.002), post hoc analysis showed that aya3,600 (p = 0.042) and aya480 (p = 0.053) 
spent more time in the inner quadrant; however, when the analysis was controlled by 
the ambulation, this significance disappeared. Also, the ratio between inner quadrant 
entries and ambulation was not significant (Linear distribution, AIC = 295.080; W(4) = 
1.390, p = 0.846). For the latency to first leave the inner quadrant, GZLM for gamma 
distribution (AIC = 411.211) showed a significant group effect (W(4) = 31.125, p < 
0.001); aya3,600 took longer to leave the inner quadrant (p = 0.020). Again, when the 
analysis was covariate by the ambulation, this significance disappeared. GZLM for 
Tweedie distribution (AIC = 499.456) detected a group effect (W(4) = 13.662, p = 
0.008) in the total time spent in rearing behaviour. Post hoc analysis showed that 
aya3,600 spent less time in rearing behaviour than the water group (p = 0.015, Figure 
4B). GZLM for Gamma distribution (AIC = 440.746) detected a group effect (W(4) = 
21.930, p < 0.001) in the latency for first appearance of vertical exploration. Post hoc 
analysis showed that aya3,600 group took more time to start exploring the open field 
than water vertically (p = 0.021). 
For the whole sample, most behaviours occurred in the outer quadrant (91%, 
n= 294.67). Immobile sniffing was the most frequent behaviour (41.41%), followed by 
horizontal exploration (24.84%), freezing (19.57%), vertical exploration (10.14%) and 
grooming (4.02%). GZLM for Gamma distribution (AIC = 416.810) detected a group 
effect (W(4) = 13.668, p = 0.008) in the frequency of freezing behaviour. Post hoc 
analysis showed that aya3,600 had less freezing behaviour than the water group (p = 
0.017, Figure 4C). GZLM for Poisson distribution (AIC = 222.335) detected a group 
effect (W(4) = 22.031, p < 0.001) in the frequency of vertical exploration in the inner 
quadrant. Post hoc analysis showed that aya3,600 had less vertical exploration in the 
inner quadrant than water group (p = 0.017) while aya120 had more vertical 
exploration (p = 0.007, Figure 4D. GZLM for Poisson distribution (AIC = 318.058) 
detected a group effect (W(4) = 10.475, p = 0.033) in the frequency of horizontal 
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exploration in the inner quadrant. Post hoc analysis showed a close significance of 
aya3,600 with less horizontal exploration in the inner quadrant than water group (p = 
0.064). GZLM for Negative Binomial distribution (AIC = 213.870) detected a group 
effect (W(4) = 17.080, p = 0.002) in the frequency of freezing behaviour in the inner 
quadrant. Post hoc analysis showed that aya480 had more freezing behaviour in the 
inner quadrant than the water group (p = 0.025). Regarding habituation, GEE for 
gamma distribution (AIC = 101.500) detected effect of both group (W(4) = 19.187, p = 
0.001), time (W(2) = 69.456, p < 0.001) but no interaction between group and time 
(W(8) = 11.751, p = 0.163). There was a decrease in ambulation from the 0-5min to 
5-10min (p<0.001) and 10-15min (p<0.001), but no differences between 5-10min and 
10-15min (p=0.122, Figure 5).  
For the behaviours transitions, GZLM for Tweedie distribution (AIC = 347.037) 
detected a group effect in the frequency of transition of horizontal exploration to 
vertical exploration behaviours (W(4) = 12.034, p = 0.017). Post hoc analysis showed 
that aya3,600 had fewer transitions when compared to water (p = 0.030, Figure 6). 
GZLM for Poisson distribution (AIC = 224.835) detected a group effect in the frequency 
of transition of the vertical exploration to freezing (W(4) = 17.761, p < 0.001); post hoc 
analysis showed that aya3,600 had fewer transitions when compared to water (p < 
0.001, Figure 6). GZLM for Gamma distribution (AIC = 408.305) detected a group 
effect in the frequency of transition from freezing to immobile sniffing behaviours (W(4) 
= 10.719, p = 0.030); post hoc analysis showed that aya120 had fewer transitions 
when compared to water (p = 0.023, Figure 6). 
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Figure 4. Effects of repeated ayahuasca administration in the open field. (A) Mean ambulation in 
the open field given by the number of crossed quadrants. *Indicates a significant difference of aya120 
group compared to water group (p = 0.055). (B) Total time spent in rearing behaviour. *Indicates a 
significant difference of aya3,600 group compared to water group (p = 0.015). (C) Frequency of freezing 
behaviour. *Indicates a significant difference of aya3,600 group compared to water group (p = 0.017). 
(D) Frequency of vertical exploration in the inner quadrant of the open field. *Indicates a significant 
difference of aya120 group compared to water group (p = 0.007). Graphic points represent mean values 
and error bars represents a 95% confidence interval bootstrapped 1,000 times for water or ayahuasca 
doses of 120 (aya120), 240(aya240), 480(aya480) and 3,600 (aya3,600) mg/kg. The number of animals 
per group is shown in parentheses below group names. 
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Figure 5. Ambulation in the open field. (A) Mean ambulation (number of crossed quadrants) in the 
open field by three blocks of 5 minutes each (0-5min, 5-10min, and 10-15min). *Indicates a significant 
time effect (p<0.001). There was a decrease in ambulation from the 0-5min to 5-10min (p<0.001) and 
10-15min (p<0.001), but it remained the same between 5-10min and 10-15min (p=0.122). Graphic 
points represent mean values and error bars represents a 95% confidence interval bootstrapped 1,000 
times for water or ayahuasca doses of 120 (aya120), 240(aya240), 480(aya480) and 3,600 (aya3,600) 
mg/kg. The number of animals per group is shown in parentheses after group names.  
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Figure 6. Path diagrams of behaviours transitions probability in the open field. Three different 
probability ranges of behaviours transitions in the open field are presented: thin dashed arrows = 0–
0.25; medium arrows = 0.25–0.50; bold arrows = 0.5–1. Circle size of behaviour is proportional to its 
frequency of occurrence. Behaviours legend, IS: immobile sniffing; HE: horizontal exploration; GR: 
grooming; FRZ: freezing; VE: vertical exploration. *Frequency of transitions significantly modified when 
compared to water group. In aya120, there was a significant decrease in the frequency of transition 
from freezing to immobile sniffing behaviour (p = 0.023). In aya3,600 there was a significant decrease 
in the frequency from vertical exploration to freezing behaviour (p<0.001) and from horizontal 
exploration to vertical exploration (p = 0.030). **A significant decrease in the frequency of freezing 
behaviour of aya3,600 group when compared to the water group (p=0.017). 
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4.4 c-Fos Expression 
 
Immunoreactive neurons nuclei for c-Fos can be seen in Figure 7. GZLM for 
Gamma distribution (AIC = 285.615) detected a group effect (W(3) = 17.859, p < 
0.001) in c-Fos expression of the anterior basolateral amygdaloid nucleus. Post hoc 
analysis showed that water group had less expression than homecage (p = 0.017), 
aya120 (p = 0.006), and aya3,600 (p = 0.002, Figure 8A). GZLM for Gamma 
distribution (AIC = 195.126) detected a group effect (W(3) = 8.654, p = 0.034) in the 
c-Fos expression of the medial CA1 region of the hippocampus. Post hoc analysis 
showed that aya3,600 had more expression than water (p = 0.053), and aya120 (p = 
0.011, Figure 8B). GZLM for Gamma distribution (AIC = 232.992) detected a group 
effect (W(3) = 11,675, p = 0.009) in the c-Fos expression of the anterior CA3 region of 
the hippocampus. Post hoc analysis showed that aya3,600 had more expression than 
homecage (p = 0.028), water (p = 0.006), and aya120 (p = 0.005, Figure 8C). Finally, 
GZLM for Gamma distribution (AIC = 370.547) detected a group effect (W(3) = 11,435, 
p = 0.01) in the c-Fos expression of the medial infra-limbic cortex region. Post hoc 
analysis showed that aya3,600 had more expression than homecage (p = 0.006), and 
water (p = 0.016, Figure 8D). All others region evaluated showed no significant 
statistical differences between groups, including the barrel field cortex (p>0.05).  
No correlations between the anterior basolateral amygdala, medial CA1, 
anterior CA3, infra-limbic cortex and behaviours were detected for the water group. 
There was a significant Spearman correlation on aya120 group between the medial 
CA1 of hippocampus with ambulation (r= -0.91 p< 0.01) and total time spent in rearing 
(r= -0.76, p= 0.015) and freezing (r= 0.78 p= 0.012) behaviour (Figure 9A, 9B, and 
9C). In the aya3,600 group there was a significant correlation between anterior CA3 
and total time spent in rearing (r= -0.71, p= 0.04) behaviour (Figure 9D). 
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Figure 7. Immunoreactive nuclei reactive for c-Fos. C-Fos expression photography taken by optic 
microscopy (Olympus) in different regions and zoom with regions marked with yellow dashed lines. 
Immunoreactive c-Fos nucleus for (A) 4x zoom medial hippocampus (A.1.: CA3; A.2.: C1, A.3.: Dentate 
Gyrus); (B) 10x zoom medial barrel field cortex (C) 10x zoom anterior infra-limbic cortex, (D) 10x zoom 
pre-limbic cortex, (E) 10x zoom medial amygdala (E.1.: lateral; E.2.: central; E.3.: basolateral); and (F) 
20x zoom immunoreactive marked nuclei. 
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Figure 8. Effect of repeated ayahuasca administration in c-Fos expression. Expression of c-Fos 
represented as cell expression by mm². (A) c-Fos expression in the anterior basolateral amygdala 
*Indicates a significant difference of water group compared to homecage (p = 0.017), aya120 (p = 
0.006), and aya3,600 (p = 0.002). (B) c-Fos expression in the medial CA1 hippocampus. *Indicates a 
significant difference of aya3,600 group compared to water (p = 0.053), and aya120 (p = 0.011). (C) c-
Fos expression in the anterior CA3 hippocampus. *Indicates a significant difference of aya3,600 group 
compared to homecage (p = 0.028), water (p = 0.006), and aya120 (p = 0.005). (D) c-Fos expression 
in the medial infralimbic cortex. *Indicates a significant difference of aya3,600 group compared 
homecage (p = 0.006), and water (p = 0.016). Graphic points represent mean values and error bar a 
95% confidence interval bootstrapped 1,000 times for homecage, water or ayahuasca doses of 120 
(aya120) and 3,600 (aya3,600) mg/kg. The number of animals per group is shown in parentheses below 
group names. 
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Figure 9. Correlation between c-Fos expression and behaviours. Spearman correlation between c-
Fos expression (cell/mm²) of structures that had between-group differences in c-Fos expression and 
behaviours in the open field. (A) A significant negative correlation between aya120 medial CA1 
hippocampus and ambulation (r= -0.91 p< 0.01). (B) A significant negative correlation between aya120 
medial CA1 hippocampus and time spent in rearing behaviour (r= -0.76, p= 0.015). (C) A significant 
negative correlation between aya120 medial CA1 hippocampus and freezing behaviour (r= 0.78 p= 
0.012). A significant positive correlation between aya3600 anterior CA3 hippocampus with total time 
spent in rearing (r= -0.71, p= 0.04). Black dots represent individuals’ values (aya120, n= 9; aya3,600 
n=8). 
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5 DISCUSSION 
 
5.1 c-Fos Expression 
 
We investigated c-Fos expression in the amygdala, hippocampus, pre- and 
infra-limbic cortex as well as the barrel field cortex - regions related to emotional 
processing, navigation-associated memory and locomotion, learning, exploration, and 
sensory processing of vibrissae after 30 days of repeated ayahuasca administration 
followed by the exposition to the open field.(61-65) 
The basolateral amygdala is an important brain region for the regulation of 
behavioural and autonomic responses to anxiogenic stimulus and attributes emotional 
aspects to a novel stimulus.(61) In our experiments, the water group showed a decrease 
in the c-Fos expression when compared to the homecage, aya120 and aya3,600 
groups. Given that anxiogenic stimulus, in general, induces the expression of c-Fos in 
the basolateral amygdala, and the exposition to the open field causes an increase in 
the c-Fos expression in its anterior part,(66, 67) it would be expected an increased c-Fos 
expression; therefore, our results would indicate an attenuated response of anxiety in 
the water group animals. On this matter, it is reasonable to investigate if the reaction 
caused by repeated gavage procedures could interfere on the behaviour since it 
produces stress-response such as the acute elevation of blood pressure and heart 
rate.(68, 69) However, chronic mild stress has different effects from our observations, 
causing an anxiogenic-like response in the open field,(70, 71) and increasing the c-Fos 
expression in the amygdala;(72) also, it’s likely that the animals have habituated to the 
gavage procedure, due to the length (30 days) of administration. Nevertheless, a study 
showed that rats under chronic stress (several exposures to the open field) had less 
c-Fos expression that rats exposed to acute stress (one exposure to the open field), 
demonstrating that the c-Fos expression in the amygdala may be modulated by 
habituation process.(73) We detected a progressive decrease of locomotion in the open 
field by all groups, indicating habituation to the apparatus; thus, it is probable that the 
analysed c-Fos expression was in a habituated period of the task, accounting for the 
reduction of expression of the water when compared to the homecage.  
The ayahuasca groups, however, did not have an increased expression of c-
Fos when compared to homecage, as would be expected after the exposure to the 
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open field, suggesting again that the anxiety response could have been attenuated. 
There are at least two possible mechanisms involving the amygdala circuitry for 
ayahuasca to attenuate an anxiety response. One would be mediated by the activation 
of the serotoninergic system in the dorsal raphe nucleus, in which through its 5-HT 
innervation in the basolateral amygdala enhances the amygdala inhibition and 
facilitates coping with stressors stimuli;(74, 75) and it is already known that ayahuasca 
induces activation of the dorsal raphe nucleus after the exposure to the open field.(25) 
Another possible (and not mutually exclusive) mechanism would be through an 
increased extracellular 5-HT in the basolateral amygdala since it has already been 
demonstrated enhanced levels of 5-HT in the amygdala followed ayahuasca ingestion 
in animals.(27) One of the effects of 5-HT in the basolateral amygdala is the 
enhancement of GABA inhibition of projections neurons by the 5-HT2a receptors, 
(76) and it has been shown that the activation of 5-HT2a receptors in the basolateral 
amygdala reduces anxiety in guinea pigs.(77) However, the effect of 5-HT activation in 
the basolateral amygdala could both attenuate and facilitate anxiety-related 
behaviours, depending on the sub-type 5-HT receptors activated. This is true for the 
5-HT2C, a much more potent agonist target of DMT: when activated, induce 
anxiogenic responses.(78-80) However, knowing of (1) a reduced c-Fos in our water 
group, (2) a demonstrated habituation in the open field, and (3) a lack of anxiolytic-
type behaviour response in the open field, it is probable that our non-observed higher 
expression of c-Fos in the experimental groups (when compared to homecage) is due 
not to an anxiolytic-type effect, but again to the habituation process. In that matter, 
there is preliminary evidence of an anxiolytic therapeutic potential of ayahuasca in 
humans,(1, 10) and such effects have already been found with beta-carbolines 
administration and with DMT alone, although somehow mixed: with an anxiogenic 
acute effect and a long-term anxiolytic effect.(20, 22) However, to the best of our 
knowledge, anxiolytic effects have never been identified in animals tested for anxiety 
that received ayahuasca. Furthermore, the results from our neurobiological data do 
not support an anxiolytic effect induced by ayahuasca assessed by the open field. Like 
the results of Pic-Taylor and colleagues,(25) we found an increased expression of c-
Fos in (a region of) the amygdala compared to the water control group, indicating that 
repeated administration had a similar profile in the emotional response of anxiogenic-
novel stimulus. 
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For the hippocampus, we observed a higher expression of c-Fos in the medial 
CA1 and the anterior CA3 in the aya3,600 group. The dorsal hippocampus contains 
the highest density of place cells coding spatial location and is involved in the cognitive 
process of learning, navigation-associated memory, exploration, and locomotion. In 
that sense, the activation of hippocampal neurons may represent the spatial/motor 
components of the open field since it is a new-open environment test related to the 
locomotor activity.(62, 63, 74, 81) Furthermore, we found a positive correlation of CA1 
activation and freezing behaviour and a negative correlation between CA1 activation 
with exploratory behaviour (ambulation and rearing) in the aya120 group but not in the 
water group. These results, together with the already demonstrated increased 5-HT in 
the hippocampus after ayahuasca administration,(27) suggest that the hippocampus 
role in the exploratory behaviour of a novel environment involves serotonergic 
pathways. However, apart from the widely DMT-serotonergic effects, other agents and 
pharmacological targets of ayahuasca also may account for its effects: this is the case 
of the MAOI, which prevent the breakdown of monoamine neurotransmitter, also 
resulting in an effect on the dopamine and epinephrine.(82) 
The activation of the infra-limbic cortex in the aya3,600 group further shows 
that ayahuasca influences emotional responses, as the medial pre-frontal cortex is 
involved in the processing of cognitively events, modulating stress responses, and 
mediating anxiety-like behaviour.(64, 83, 84) It is known that ayahuasca has effects in the 
cortex in human,(15, 16, 18, 19) but studies assessing the effects on the long-term usage 
both in humans and non-human animals are scarce. To our knowledge, the only data 
assessing long-term ayahuasca effects in the pre-frontal cortex is a study from Bouso 
et al. (2015),(19) showing that long-term ayahuasca use was associated with cortical 
thickness in midline structures of the brain and that the continued use of ayahuasca 
throughout life can potentially lead to structural brain changes in humans. Here we 
showed for the first time an activation in the region of the pre-frontal cortex in rodents 
that received ayahuasca. 
Finally, we evaluated c-Fos expression in the barrel field cortex, a region of the 
rodent brain related to the sensorial aspects of vibrissae in mammals that make use it 
to explore the environment, to control any alteration of the spatial localization of the 
animals in the open field.(65) The rats’ vibrissae have a fundamental role in the 
assessment of the anxiety in the open field (i.e., thigmotaxis behaviour), and the 
31 
 
 
vibrissae have a strongly influence in the interaction with the world, especially its 
locomotor aspect;(65) for instance, rats that have their vibrissae removed spend more 
time in the centre of the open field.(41) Is known that ayahuasca induces visual effects 
in humans, even with the eyes shut;(17) thus, it’s reasonable to think that in rodents it 
could have effects in the sensory part of vibrissae. We found no differences in the c-
Fos expression in the barrel field cortex, suggesting that repeated administration of 
ayahuasca has no significant effect on the sensory vibrissae area activation. This non-
difference though, serve as control by showing that ayahuasca did not indistinctly alter 
c-Fos expression throughout the brain, especially in our highest dose.  
It is known that the activation of 5-HT2a receptors stimulates the expression of 
immediate early genes, including c-Fos in the medial prefrontal and anterior cingulate 
cortices, it can modulate the plasticity of synapses by increasing brain-derived 
neurotrophic factor  and inducing the expression of transcription factors egr-1 and egr-
2 and may also (Frankel, 2002, Gewirtz, 2002, Soul’e, 2006, moreno, 2013, O`dovan, 
1999).  
 
 
5.2 Behaviour 
 
We investigated the effect of ayahuasca on the behaviour of rats that received 
repeated doses of ayahuasca for thirty days, evaluating the effects acutely on day one, 
and repeatedly on day 15 and day 30. 
 
5.2.1 Open Field 
  
It is known that the acute administration of full or partial agonist of 5-HT1A 
receptors, a targeted agonist of the DMT present in ayahuasca, often induces 
anxiolytic-like effects in rodents measured by the parameters of the open field.(41, 60) 
Our result shows an increase in both time spent in the inner quadrant and the latency 
to first get out of the centre in the aya480 and aya3,600 groups, which would indicate 
an anxiolytic behaviour - since rodents tend to stay in the open field periphery; 
however, this difference disappears when the analysis is controlled by the total 
32 
 
 
ambulation, suggesting that the increased time in the centre is due to an unspecific 
modification of the ambulation, rather than an anxiolytic effect. Another measure of 
anxiety, the ration between inner quadrant entries and ambulation, haven’t changed 
in any group. Lower frequency of freezing behaviour could be interpreted as a less 
defensive-like response by the aya3,600 group; however, as the total time spent in 
freezing hasn’t changed, this difference indicates that the effect is due to reduced 
activity by the animals; also, we detected a lower frequency of vertical exploration in 
the inner quadrant in this group. In aya120, our lowest dosage group, we detected an 
increase of locomotion and an increase in the quantity of rearing behaviour in the inner 
quadrant, this increased activity was also observed in the ethogram, since there was 
a reduction in the transition from the freezing to idle behaviour. Increased locomotion 
in the open field is associated with stimulant effects.(41) It’s known that the central 
stimulation of 5-HT causes hyperlocomotion(85) and similar result was shown acutely 
with others psychedelics, lysergic acid diethylamide (LSD), in which has increased 
locomotion and rearing in the open field with low doses and with DOI, selective 5-HT2 
receptor agonist, which causes a 5-HT2A-dependent increase in locomotion.(86, 87) 
Likewise, 5-HT2A receptors action stimulate the release of dopamine from the 
mesoaccumbens,(88) and dopamine action in the nuclei accumbens induce 
hyperlocomotion. (89) Furthermore, the chronic administration of LSD lead to alteration 
of dopaminergic and serotonergic genes expression, even after cessation of drug 
exposure; (90) therefore, the enhanced locomotion found in our group may be due to 
the ayahuasca effects on the serotoninergic system. 
While the decrease of vertical activity together with the decrease of locomotion 
in the open field is related to an effect of sedation,(41) we observed only a reduction in 
the vertical activity on the aya3,600 group. One possible explanation for the lower 
locomotor activity of our highest dose would be due to stimulant effect, in which could 
cause higher stereotyped behaviours (e.g. sniffing, licking etc.) that would compete 
with ambulation, as it happens with some amphetamine drugs;(91) however, our 
ethogram hasn’t detected any major modification of such behaviours in our highest 
dose group. It’s known that ayahuasca often induces adverse reactions in human, 
causing nausea and/or diarrhoea, probably due to the increase of vagal stimulation by 
central 5-HT and peripheral increase of 5-HT.(51) It is possible that these types of 
effects could account for the decreased activity observed, especially considering that 
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rats lack emetic responses and ayahuasca cannot be purged from the body. 
Accordingly, the presence of diarrhoea was observed in some animals (data not 
shown) and we found a significantly lower weight gain by the rats in this group. It is 
known that intermittent administration of moderate dose of ayahuasca does not 
interfere the weight gain of mice(39) and studies with repeated administration on 
gestational rats with a dose 8-fold the usually taken by human found difference on 
food consumption but not on the weight gain.(38, 92) However, in accordance with our 
results, with a higher dosage, the weight gain of maternal rats decreases.(93) Also, 
lithium chloride, a toxin that induces vomiting in animals with emetic reflex and 
symptoms consistent with visceral illness in rats,(94, 95) has a similar effect profile: 
decreases food consumption and the exploratory behaviour of rats in the open field.(96, 
97) Thus, the reduced activity in the aya3,600 group is probably due to 
adverse/peripheral effects of ayahuasca, instead of a sedative effect. Furthermore, we 
detected no effect on any anxiety parameters evaluated by the open field in any of the 
doses studied, indicating that repeated administration of ayahuasca does not induce 
anxiolytic- or anxiogenic-like behaviours effects measured by the open field. Also, we 
showed previously that repeated administration of ayahuasca does not affect the 
performance of rats in the elevated plus-maze when tested in an off-drug state, a 
widely used apparatus to measure anxiety.(40) In both studies of our laboratory, we 
found behavioural effects with our lower (same DMT-standardized) dose, which would 
correspond to a half dose of a human common-ritual dose; however, following the 
principle of interspecies drug dose scaling, smaller animals need higher dosages to 
achieve the same effects of humans.(98) Therefore, is possible that the 120mg/kg may 
correspond to an even lower dose for rats. These long-term lower-dose behaviour 
modification found by our research group, together with a chronic-internment DMT 
micro dose effect in mood and anxiety in rats(99) highlight the importance of studying 
ayahuasca low and micro-dosage effects. 
Finally, the majority of behaviours assessed in the open field occurred in the 
outer part of it, in accordance with the literature that rats tend to stay close to the wall, 
a behaviour named thigmotaxis.(41) The stochastic analysis (i.e., behaviour transition-
probability based on the animal’s ethogram) showed that all behaviours in the water 
group converted into immobile sniffing, which has been already hypothesized to 
represent a key element in behavioural switching process related to environmental 
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exploration.(100) This convergence pattern was also presented by all groups (Figure 5), 
showing that different repeated doses of ayahuasca, including an extremely high one, 
does not alter the sequential structure of exploratory behaviour. In sum, our 
behavioural results from the open field showed that repeated ayahuasca 
administration increased locomotion in the aya120 group, caused a reduction of 
activity in the aya3,600 group, while no modification was found in the intermediate 
groups (aya240 and aya480); furthermore, a similar behaviour pattern (i.e., probability 
of transitions) was found across all groups.  
 
5.2.2 Day one and 15 
 
Regarding the acute effect of ayahuasca (i.e., our first day of administration), it 
has been previously shown to decrease locomotion in the open field, an effect similar 
to the selective serotonin reuptake inhibitor fluoxetine.(24, 25) We observed no acute 
effect in the activity, and from day one to day 15 all groups but aya120 and aya3,600 
had their vertical exploration (i.e., rearing) decreased. The reduction of exploration 
from day one to day 15 is due to a phenomenon called habituation, and the absence 
of discriminant can be interpreted as a decreased habituation to the experimental in 
the case of aya120 animals, which can be due to impaired learning or to the fact that 
this dose enhances activity, and this was not seen in day one. This differences in the 
results may be due to the type of apparatus utilized, given that we have used an acrylic 
cage on the first day instead of the open field, which has more space for horizontal 
exploration. Comparing our lower dose results with the acute effect reported by Lima 
et al.,(24) we could show a profile partially similar to the monoamine oxidase inhibitors 
antidepressants in the open field: an acute administration of it reduces ambulation 
while the chronic administration increases it (101, 102). These results, together with the 
inhibit monoamine oxidase beta-carbolines actions, may indicate an antidepressant 
behaviour profile, but further investigation would be needed to make such affirmation, 
since no antidepressant control was used. Altogether, these findings suggest that the 
low dose used may have different effects profile depending on the length it is 
administered. Finally, the aya3,600 dose indicates a different profile when evaluated 
on the first day, which animals showed fewer vertical exploration. Because of the 
habituation process from day one to 15, we would expect even a further decrease in 
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this behaviour, which was not the case probably by the nature of the variable that 
started already low in frequency in the first day and may have reached a ground effect.  
This study has some limitations. Our study design does not reflect a pattern of 
long-dated ritualistic ayahuasca users – which usually uses ayahuasca intermittently 
for extended periods.(103) We focused on the neurobiological effects of ayahuasca 
evidenced by an intensive-period of use (i.e., administration). Studies with intermittent 
administration, for example Netto et al. (2017),(39) are closer to reproduce - at least a 
significant portion - the ayahuasca used by humans. Furthermore, we cannot promptly 
segregate the long-term from the acute effects because we lack groups for comparison 
(e.g., long-term- and acute-only groups). However, the differences between our results 
to those reported by Pic-Taylor and colleagues with an acute intervention suggest that 
our effects are related to the long-standing effect of ayahuasca. While in both studies, 
extreme ayahuasca dose (i.e., 15x or 30x) decreased activity of rats, when comparing 
to water treated group, neurobiological results are different: Pic-Taylor et al.(25) found 
a significant increase in c-Fos expression in the basolateral posterior amygdaloid 
nucleus, and CA1, CA3 and dentate gyrus of the hippocampus with a 30x ayahuasca 
dose (comparable to our highest dose), while we found only difference in the anterior 
part of the amygdala, in the medial CA1, and the anterior CA3 for the compatible dose.  
In summary, we found that different doses of ayahuasca have a different profile 
of effect in the open field and the length of administration also affects it, showing that 
ayahuasca may influence the locomotor response in rats. Repeatedly low doses of 
ayahuasca increase activity in a novel environment, and extremely high doses 
decrease the activity while intermediate doses have no effect on the behaviour. Acute 
low and intermediate doses of ayahuasca does not affect the behaviour, but extremely 
high doses decrease the activity of rats acutely. Despite its different dose-dependent 
effects, repeated ayahuasca does not alter the sequential structure of exploratory 
behaviour after repeated administration, even with an extremely high dose. Apart from 
a reduced weight gain and activity, repeated extreme high doses of ayahuasca, up to 
15 folds higher what would be normally seen in several human contexts, does not 
cause severe observable impairment on animals, providing further data regarding the 
safety of ayahuasca intake. Furthermore, we showed for the first time that repeated 
administration of ayahuasca influences neural mechanisms when rats are exploring a 
new-anxiogenic environment. Also, our study is the first to show correlations between 
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rat’s behaviours and brain activation after ayahuasca administration, and the first to 
show the activation of the pre-frontal cortex by ayahuasca in rats, adding relevant 
material to the neurobiological literature of ayahuasca - specifically regarding the 
repeated/chronic ingestion. Finally, neither behavioural nor neurobiological effects 
related to anxiety assessed by the open field were identified in our study. 
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6 CONCLUSION 
 
Our results show that ayahuasca administration acts in brain regions related 
learning and emotional processing with serotonergic pathways, indicating a plastic 
process; it also interferes on the locomotor activity of rats in different ways (i.e., 
increasing or decreasing activity) depending on the dosage regardless the sensorial 
effect on the vibrissae, but not on the locomotor-dependent anxiety response of a 
novel environment. Even in extreme-high repeated doses, no serious impairment was 
observed, and behavioural structure remained similar between other groups, despite 
a lower weight gain. Our data add evidence for the neurobiological and behavioural 
effects of ayahuasca, and together with Favaro et al. (2015)(40) findings, indicate that 
low ayahuasca doses should be a focus of investigation. Although these findings 
cannot be ready extrapolated to humans, it highlights the importance to investigate the 
effects of lower, including micro, ayahuasca doses than the commonly used in rituals. 
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